Futoshi Kurimoto

1.2k total citations
27 papers, 388 citations indexed

About

Futoshi Kurimoto is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Molecular Biology. According to data from OpenAlex, Futoshi Kurimoto has authored 27 papers receiving a total of 388 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Pulmonary and Respiratory Medicine, 14 papers in Oncology and 9 papers in Molecular Biology. Recurrent topics in Futoshi Kurimoto's work include Lung Cancer Treatments and Mutations (9 papers), Lung Cancer Research Studies (7 papers) and Neuroendocrine Tumor Research Advances (3 papers). Futoshi Kurimoto is often cited by papers focused on Lung Cancer Treatments and Mutations (9 papers), Lung Cancer Research Studies (7 papers) and Neuroendocrine Tumor Research Advances (3 papers). Futoshi Kurimoto collaborates with scholars based in Japan and Greece. Futoshi Kurimoto's co-authors include Masahiro Seike, Akihiko Gemma, Shoji Kudoh, Yoko Hosoya, Kazutsugu Uematsu, Akinobu Yoshimura, Suguru Hibino, Masahiko Shibuya, Hiroshi Sakai and K. Takenaka and has published in prestigious journals such as Circulation, Journal of Clinical Oncology and International Journal of Radiation Oncology*Biology*Physics.

In The Last Decade

Futoshi Kurimoto

27 papers receiving 378 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Futoshi Kurimoto Japan 12 188 151 116 59 54 27 388
William Koss United States 9 139 0.7× 157 1.0× 84 0.7× 40 0.7× 38 0.7× 19 426
Norishige Iizuka Japan 12 157 0.8× 101 0.7× 131 1.1× 109 1.8× 78 1.4× 27 399
Tonia Kim United States 4 117 0.6× 51 0.3× 69 0.6× 75 1.3× 41 0.8× 7 256
Alan Koterba United States 12 120 0.6× 75 0.5× 59 0.5× 26 0.4× 26 0.5× 21 386
Liang Zhu China 15 359 1.9× 129 0.9× 193 1.7× 36 0.6× 71 1.3× 35 602
Britt Hanson United Kingdom 11 242 1.3× 103 0.7× 49 0.4× 32 0.5× 44 0.8× 19 511
Yinan Guo China 12 240 1.3× 102 0.7× 114 1.0× 22 0.4× 38 0.7× 32 434
Jinping Lu China 10 172 0.9× 77 0.5× 38 0.3× 29 0.5× 44 0.8× 12 296
Anal Desai United States 5 268 1.4× 53 0.4× 40 0.3× 40 0.7× 58 1.1× 5 412

Countries citing papers authored by Futoshi Kurimoto

Since Specialization
Citations

This map shows the geographic impact of Futoshi Kurimoto's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Futoshi Kurimoto with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Futoshi Kurimoto more than expected).

Fields of papers citing papers by Futoshi Kurimoto

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Futoshi Kurimoto. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Futoshi Kurimoto. The network helps show where Futoshi Kurimoto may publish in the future.

Co-authorship network of co-authors of Futoshi Kurimoto

This figure shows the co-authorship network connecting the top 25 collaborators of Futoshi Kurimoto. A scholar is included among the top collaborators of Futoshi Kurimoto based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Futoshi Kurimoto. Futoshi Kurimoto is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Tozuka, Takehiro, Rintaro Noro, Hideaki Mizutani, et al.. (2024). Osimertinib plus local treatment for brain metastases versus osimertinib alone in patients with EGFR-Mutant Non-Small Cell Lung Cancer. Lung Cancer. 191. 107540–107540. 9 indexed citations
2.
Kato, Yasuhiro, Gou Yamamoto, Yasutaka Watanabe, et al.. (2021). Long-term efficacy of immune checkpoint inhibitors in non-small cell lung cancer patients harboring MET exon 14 skipping mutations. International Journal of Clinical Oncology. 26(6). 1065–1072. 5 indexed citations
3.
Kurimoto, Futoshi, et al.. (2020). A Rare Case of Eosinophilic Granulomatosis with Polyangiitis Presenting as Ischemic Stroke and Splenic Infarction. Journal of Stroke and Cerebrovascular Diseases. 30(3). 105539–105539. 6 indexed citations
4.
Kato, Yasuhiro, Yasutaka Watanabe, Yuki Yamane, et al.. (2020). Reactivation of TB During Administration of Durvalumab After Chemoradiotherapy for Non-Small-Cell Lung Cancer: A Case Report. Immunotherapy. 12(6). 373–378. 12 indexed citations
5.
Horinouchi, Hidehito, Kaoru Kubota, Akihiko Miyanaga, et al.. (2018). Oral rehydration solution (OS-1) as a substitute of intravenous hydration after cisplatin administration in patients with lung cancer: a prospective multicenter trial. ESMO Open. 3(1). e000288–e000288. 11 indexed citations
6.
Yamamoto, Gou, Mari Kikuchi, Shiho Kobayashi, et al.. (2017). Routine genetic testing of lung cancer specimens derived from surgery, bronchoscopy and fluid aspiration by next generation sequencing. International Journal of Oncology. 50(5). 1579–1589. 13 indexed citations
7.
Uramoto, Hidetaka, Hirohiko Akiyama, Yuki Nakajima, et al.. (2014). The Long-Term Outcomes of Induction Chemoradiotherapy Followed by Surgery for Locally Advanced Non-Small Cell Lung Cancer. Case Reports in Oncology. 7(3). 700–710. 10 indexed citations
8.
Saitoh, Jun‐ichi, Yoshihiro Saito, Tomoko Kazumoto, et al.. (2011). Concurrent Chemoradiotherapy Followed by Consolidation Chemotherapy With Bi-Weekly Docetaxel and Carboplatin for Stage III Unresectable, Non-Small-Cell Lung Cancer: Clinical Application of a Protocol Used in a Previous Phase II Study. International Journal of Radiation Oncology*Biology*Physics. 82(5). 1791–1796. 16 indexed citations
9.
Isobe, Kazutoshi, Kunihiko Kobayashi, Seiji Kosaihira, et al.. (2009). Phase II study of nimustine hydrochloride (ACNU) plus paclitaxel for refractory small cell lung cancer. Lung Cancer. 66(3). 350–354. 4 indexed citations
10.
11.
Gemma, Akihiko, Yoko Hosoya, Kuniko Matsuda, et al.. (2003). Reduced transcription of the RB2/p130 gene in human lung cancer. Molecular Carcinogenesis. 38(3). 124–129. 13 indexed citations
12.
Ando, Masahiro, Kunihiko Kobayashi, Akinobu Yoshimura, et al.. (2003). Weekly administration of irinotecan (CPT-11) plus cisplatin for refractory or relapsed small cell lung cancer. Lung Cancer. 44(1). 121–127. 30 indexed citations
13.
Seike, Masahiro, Akihiko Gemma, Yoko Hosoya, et al.. (2002). The promoter region of the human BUBR1 gene and its expression analysis in lung cancer. Lung Cancer. 38(3). 229–234. 21 indexed citations
14.
Gemma, Akihiko, Yoko Hosoya, Masahiro Seike, et al.. (2001). Genomic structure of the human MAD2 gene and mutation analysis in human lung and breast cancers. Lung Cancer. 32(3). 289–295. 39 indexed citations
15.
Kurimoto, Futoshi, Akihiko Gemma, Yoko Hosoya, et al.. (2001). Unchanged frequency of loss of heterozygosity and size of the deleted region at 8p21-23 during metastasis of lung cancer. International Journal of Molecular Medicine. 8(1). 89–93. 12 indexed citations
16.
Gemma, Akihiko, K. Takenaka, Yoko Hosoya, et al.. (2001). Altered expression of several genes in highly metastatic subpopulations of a human pulmonary adenocarcinoma cell line. European Journal of Cancer. 37(12). 1554–1561. 73 indexed citations
17.
18.
Hosoya, Yoko, Akihiko Gemma, Masahiro Seike, et al.. (1999). Alteration of the PTEN/MMAC1 gene locus in primary lung cancer with distant metastasis. Lung Cancer. 25(2). 87–93. 21 indexed citations
19.
Tsuchimochi, Hidetsugu, Futoshi Kurimoto, Hiroshi Koyama, et al.. (1988). Atrial natriuretic peptide distribution in fetal and failed adult human hearts.. Circulation. 78(4). 920–927. 49 indexed citations
20.
Fujita, Yasunori, et al.. (1984). Effects of Feed Restriction and Switching the Diet on Proteinuria in Male Wistar Rats. Journal of Gerontology. 39(5). 531–537. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by William Koss Breakdown of academic impact, for papers by Norishige Iizuka Breakdown of academic impact, for papers by Tonia Kim Breakdown of academic impact, for papers by Alan Koterba Breakdown of academic impact, for papers by Liang Zhu Breakdown of academic impact, for papers by Britt Hanson Breakdown of academic impact, for papers by Yinan Guo Breakdown of academic impact, for papers by Jinping Lu Breakdown of academic impact, for papers by Anal Desai
Rankless by CCL
2026